SCHEMBL7093383

SCHEMBL7093383

CC1Oc2ccc(C(Cc3ccc(Cl)cc3Cl)NC(=O)OC(C)(C)C)cc2NC1=S

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TP53 P04637 2/20 0.40
HSD17B10 Q99714 2/20 0.38
IDO1 P14902 2/20 0.37
ALDH1A1 P00352 5/20 0.35
HPGD P15428 3/20 0.35
KDM4E B2RXH2 3/20 0.35
HTT P42858 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MAPT P10636 2/20 0.34
GLA P06280 1/20 0.34
XBP1 P17861 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
GAA P10253 2/20 0.34
PKM P14618 1/20 0.34
ALOX12 P18054 1/20 0.34
CYP3A4 P08684 3/20 0.33
HDAC8 Q9BY41 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708210 0.91 MC4R (0.41) MC4RSMN1; SMN2TP53HSD17B10IDO1
SCHEMBL7087735 0.91 MC4R (0.36) MC4RHSD17B10IDO1ALDH1A1HPGD
SCHEMBL7092472 0.89 HSD17B10 (0.37) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD
SCHEMBL7708252 0.87 CTSL (0.45) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD
SCHEMBL7708478 0.86 HSD17B10 (0.35) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD
SCHEMBL7091267 0.86 HSD17B10 (0.33) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD
SCHEMBL7095873 0.84 CTSS (0.42) TP53HSD17B10IDO1ALDH1A1HPGD
SCHEMBL7704943 0.84 ALDH1A1 (0.43) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD
SCHEMBL7091085 0.83 NPSR1 (0.35) SMN1; SMN2TP53HSD17B10IDO1ALDH1A1
SCHEMBL7094067 0.83 HPGD (0.41) SMN1; SMN2TP53HSD17B10ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed